Childhood rhabdomyosarcoma is a rare type of cancer that forms in the soft tissues of children, commonly in muscles attached to bones. Despite its rarity, it's one of the most common soft tissue sarcomas in children. Research in this area focuses on understanding the genetic mutations driving its development and identifying more effective treatment strategies. Recent advancements in cancer research have led to targeted therapies that aim to inhibit specific molecular pathways involved in tumor growth. Additionally, immunotherapy approaches, harnessing the body's immune system to target cancer cells, show promise in treating childhood rhabdomyosarcoma. Collaborative efforts among researchers worldwide continue to push the boundaries in improving outcomes for children battling this aggressive cancer.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States